NextCure to Present at BTIG Virtual Biotechnology Conference
BELTSVILLE, Md., Aug. 05, 2020 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]
Zscaler Internet Access Achieves FedRAMP “In Process” Status at High Impact Level
SAN JOSE, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced […]
Pacific Mercantile Bancorp Reports Second Quarter 2020 Operating Results
Second Quarter SummaryNet income of $1.9 million, or $0.08 per fully diluted shareFunded $280.3 million of Paycheck Protection Program (“PPP”) […]
Pfizer and BioNTech to Supply Canada with their BNT162 mRNA-Based Vaccine Candidate
Supply to be provided over the course of 2021, subject to Health Canada approvalAgreement is part of Pfizer’s and BioNTech’s […]
Vericel Reports Second Quarter 2020 Financial Results
Product Revenues of $20.0 Million Reported for the Second QuarterConference Call Today at 8:30am Eastern TimeCAMBRIDGE, Mass., Aug. 05, 2020 […]
Arbutus to Present at Wedbush PacGrow Healthcare Virtual Conference
WARMINSTER, Pa., Aug. 05, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on […]
DLH Announces Appointment to its Board of Directors
ATLANTA, Aug. 05, 2020 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”) today announced the appointment […]
The French Red Cross Selects Cellocator by PowerFleet for COVID-19 Humanitarian Response
WOODCLIFF LAKE, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) — Cellocator by PowerFleet, Inc. (Nasdaq: PWFL), a global leader and provider […]
Daré Bioscience to Host Second Quarter 2020 Financial Results and Company Update Conference Call and Webcast on August 12, 2020
SAN DIEGO, Aug. 05, 2020 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced […]
Allena Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update
— Expanding URIROX-2 Trial Sites; Interim Analysis on Track for the First Quarter of 2022 –-— Initiated Phase 1 Clinical […]
